Ravandi F, Senapati J, Jain N, Short NJ, et al. Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma. Leukemia 2024 Sep 25. doi: 10.1038/s41375-024-02414.
PMID: 39322712